NCT03706235View on ClinicalTrials.gov

Colvera for Detection of Disease Recurrence

CompletedOBSERVATIONAL
Enrollment

488

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

August 16, 2019

Study Completion Date

April 29, 2020

Conditions
Colorectal Adenocarcinoma
Interventions
OTHER

Blood draw (venipuncture)

Draw 40 mls of blood from eligible subjects. Process and ship samples to sponsor.

Trial Locations (12)

14263

Roswell Park Cancer Institute, Buffalo

19901

Bayhealth, Dover

44106

University Hospitals, Cleveland

46202

Indiana University, Indianapolis

48374

Providence Hospital-Ascension Health, Novi

55407

Virginia Piper Cancer Institute-Allina Health, Minneapolis

60201

NorthShore Health System, Evanston

60612

Rush University Medical Center, Chicago

70001

Colon and Rectal Surgery Associates, Metairie

77030

Baylor College of Medicine, Houston

90277

Torrance Memorial Physician Network, Redondo Beach

07109

Essex Oncology, Belleville

Sponsors
All Listed Sponsors
lead

Clinical Genomics Pathology

INDUSTRY

NCT03706235 - Colvera for Detection of Disease Recurrence | Biotech Hunter | Biotech Hunter